Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial.

Source:http://linkedlifedata.com/resource/pubmed/id/21459795

Download in:

View as

General Info

PMID
21459795